Latest News

Filters

Filter by tags: United States South Africa Canada Clear all tag filters

15 news articles found


X-Energy UK Holdings, a wholly-owned subsidiary of US-based X-energy Reactor Company and Cavendish Nuclear, a wholly-owned subsidiary of Babcock International have been awarded funding from the UK Government’s Future Nuclear Enabling Fund (FNEF) to further the development of their plans to deploy Xe-100 advanced modular reactors (AMRs) in the UK. The government’s £3.34m ($4.23m) will be matched by X-energy for a total programme of £6.68m. The funds will be used to develop UK-specific deployment plans including an assessment of domestic manufacturing and supply chain opportunities, constructability, modularisation studies, and fuel management.

Date: Thursday, 11 April 2024
Original article: neimagazine.com/news/newsfunding-secured-to-accelerate-xe-100-deployment-in-the-uk-11671126

US-based X-energy Reactor Company and Canadian power company TransAlta Corporation have announced a partnership to study deployment of X-energy’s Xe-100 small modular reactors (SMRs) in Alberta. The study will be supported through funding from Emissions Reduction Alberta (ERA) and will assess the feasibility of repurposing a fossil fuel electricity generation site for an Xe-100 plant.

Date: Friday, 05 April 2024
Original article: neimagazine.com/news/newsx-energy-and-transalta-to-assess-use-of-xe-100-smrs-in-alberta-11658926

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

Bangladesh is committed to continuous improvement of nuclear and radiation safety, an International Atomic Energy Agency (IAEA) team of experts has concluded. The Integrated Regulatory Review Service (IRRS) mission team identified areas for possible improvements.

Date: Friday, 16 December 2022
Original article: world-nuclear-news.org/Articles/IAEA-says-Bangladesh-committed-to-nuclear-safety

An International Atomic Energy Agency (IAEA) Integrated Regulatory Review Service (IRRS) mission said Bangladesh is committed to continuous improvement of nuclear and radiation safety. The mission also noted areas where improvements could be made to enhance the national nuclear and radiation safety regulatory infrastructure, as the country constructs its first nuclear power plant (NPP).

Date: Wednesday, 14 December 2022
Original article: neimagazine.com/news/newsiaea-reviews-bangladeshs-regulatory-framework-10433302

All realistic options that might contribute to global net-zero must be considered, the Generation IV International Forum (GIF) has said in an open letter to COP26 President Alok Sharma. Nuclear systems and advanced reactors - such as Generation IV systems - can contribute to a net-zero society alongside renewable energies, it says.

Date: Saturday, 30 October 2021
Original article: world-nuclear-news.org/Articles/GIF-calls-for-nuclear-s-inclusion-in-COP26-discuss

Nuclear energy, as an asset class, has the potential to report well against a wide range of Environmental, Social and Governance (ESG) data collection and accounting metrics, according to a new report from the Generation IV International Forum (GIF). This should allow nuclear energy to be considered as an investable asset class, thereby allowing nuclear companies and projects to access climate finance.

Date: Wednesday, 08 September 2021
Original article: world-nuclear-news.org/Articles/GIF-highlights-nuclear-s-ESG-attributes

There is growing interest in nuclear power across several African countries. The USA could be more engaged to create more equitable and sustainable deployment of clean nuclear power on the African continent, write Jessica Lovering and Kenton de Kirby of the Breakthrough Institute.

Date: Friday, 11 January 2019
Original article: world-nuclear-news.org/Articles/Viewpoint-Why-the-USA-should-partner-with-Africa-t

The UK government’s plans to leave the European Union (EU), and consequently the European Atomic Energy Community (Euratom), could threaten plans to build new nuclear reactors and decommissioning activities, as well as jeopardise energy security due to the impact on nuclear fuel supplies, according to a new report by the Institution of Mechanical Engineers (IMech). The intention that the UK should leave Euratom was announced in the recent ‘Brexit Bill’, in part due to Euratom being enforced by the European Court of Justice and managed by EU institutions.

Date: Monday, 20 February 2017
Original article: neimagazine.com/news/newsmore-concern-over-brexit-5743855